News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
345,837 Results
Type
Article (24468)
Company Profile (286)
Press Release (321073)
Multimedia
Podcasts (159)
Webinars (13)
Section
Business (103075)
Career Advice (210)
Deals (15099)
Drug Delivery (82)
Drug Development (55463)
Employer Resources (41)
FDA (7087)
Job Trends (6125)
News (164330)
Policy (11846)
Tag
2025 Best Places to Work (14)
2026 Best Places to Work (20)
2027 BioCapital Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (6)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (1357)
Academic (1)
Accelerated approval (51)
ADA (35)
Adcomms (20)
Allergies (130)
Alliances (25583)
ALS (214)
Alzheimer's disease (1339)
Antibody-drug conjugate (ADC) (603)
Approvals (7501)
Artificial intelligence (544)
ASCO (249)
Autoimmune disease (435)
Automation (30)
Bankruptcy (124)
Belgium (30)
Best Places to Work (5261)
BIO (60)
Biologics (89)
BIOSECURE Act (8)
Biosimilars (169)
BioSpace Insights (102)
Biotechnology (192)
Bispecific (55)
Bladder cancer (157)
Brain cancer (78)
Breast cancer (618)
Cancer (5557)
Cardiovascular disease (397)
Career advice (211)
Career pathing (16)
CAR-T (379)
CDC (14)
CDMO (150)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1048)
Cervical cancer (32)
Clinical research (50146)
Collaboration (1936)
Commercialization (47)
Company closure (4)
Compensation (1112)
Complete response letters (83)
COVID-19 (1307)
CRISPR (149)
CRO (7)
C-suite (1102)
Cystic fibrosis (166)
Data (8240)
Decentralized trials (1)
Denatured (36)
Depression (139)
Dermatology (138)
Diabetes (432)
Diagnostics (2768)
Digital health (22)
Diversity (6)
Diversity, equity & inclusion (11)
Drug discovery (382)
Drug pricing (61)
Drug shortages (4)
Duchenne muscular dystrophy (379)
Earnings (38167)
Editorial (41)
Employer branding (7)
Employer resources (40)
ESMO (333)
Events (62432)
Executive appointments (831)
Eye disease (18)
FDA (10142)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (41)
Funding (1568)
Gene editing (315)
Generative AI (56)
Gene therapy (986)
GLP-1 (675)
Government (1471)
Grass and pollen (3)
Guidances (205)
Healthcare (7830)
Hematology (163)
HIV (44)
Huntington's disease (89)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (129)
Immunology and inflammation (304)
Immuno-oncology (128)
Indications (205)
Infectious disease (1510)
Inflammatory bowel disease (219)
Inflation Reduction Act (10)
Influenza (71)
Intellectual property (278)
Interviews (28)
IPO (8104)
IRA (15)
Job creations (1084)
Job search strategy (171)
JPM (46)
Kidney cancer (19)
Kidney disease (134)
Labor market (52)
Layoffs (321)
Leadership (22)
Legal (1824)
Licensing (108)
Liver cancer (61)
Longevity (42)
Lung cancer (770)
Lung diease (21)
Lymphoma (402)
Machine learning (41)
Management (9)
Manufacturing (867)
Marketing (30)
MASH (195)
Medical affairs (4)
Medical device (2890)
Medtech (2948)
Melanoma (148)
Mergers & acquisitions (7932)
Metabolic disorders (1202)
Middle East (1)
mRNA (242)
Multiple sclerosis (181)
Multispecific (7)
NASH (15)
Netherlands (21)
Neurodegenerative disease (469)
Neuropsychiatric disorders (109)
Neuroscience (2961)
Neurotech (2)
NextGen: Class of 2026 (2291)
Non-profit (1157)
Now hiring (53)
Obesity (543)
Opinion (189)
Ovarian cancer (237)
Pain (185)
Pancreatic cancer (325)
Parkinson's disease (379)
Partnered (24)
Patents (531)
Patient advocacy (7)
Patient recruitment (704)
Patient selection (96)
Peanut (55)
People (30564)
Peptides (34)
Pharmaceutical (33)
Pharmacy benefit managers (10)
Phase 1 (17646)
Phase 2 (23106)
Phase 3 (15070)
Pipeline (9903)
Policy (153)
Postmarket research (980)
Preclinical (7574)
Press Release (72)
Prostate cancer (277)
Psychedelics (92)
Radioligand (3)
Radiopharmaceuticals (347)
Rare diseases (1328)
Real estate (1786)
Recruiting (18)
Regenerative medicine (29)
Regulatory (12995)
Reports (38)
Research institute (1363)
Resumes & cover letters (25)
Rett syndrome (60)
RNA editing (38)
RSV (29)
Schizophrenia (177)
Series A (302)
Series B (200)
Series C (1)
Service/supplier (2)
Sickle cell disease (138)
Special edition (26)
Spinal muscular atrophy (168)
Sponsored (31)
Startups (2256)
State (1)
Stem cells (8)
Stomach cancer (13)
Substance use disorders (20)
Supply chain (57)
Switzerland (16)
Tariffs (29)
Tax incentives (1)
The Weekly (121)
Vaccines (517)
Venture capital (126)
Weight loss (286)
Wet AMD (7)
Women's health (68)
Women in leadership (1)
Worklife (4)
Date
Today (1)
Last 7 days (423)
Last 30 days (2234)
Last 365 days (19830)
2026 (18243)
2025 (19549)
2024 (22304)
2023 (24669)
2022 (29728)
2021 (30815)
2020 (26231)
2019 (18536)
2018 (13381)
2017 (15610)
2016 (13831)
2015 (16457)
2014 (11958)
2013 (18388)
2012 (8994)
2011 (8913)
2010 (8648)
Location
Africa (211)
Alabama (90)
Alaska (3)
Arizona (135)
Arkansas (6)
Asia (22109)
Australia (3955)
California (11275)
Canada (2686)
China (1441)
Colorado (414)
Connecticut (440)
Delaware (379)
Europe (49188)
Florida (1441)
Georgia (300)
Hawaii (3)
Idaho (21)
Illinois (719)
India (82)
Indiana (272)
Iowa (20)
Japan (474)
Kansas (97)
Kentucky (21)
Louisiana (21)
Maine (14)
Maryland (1176)
Massachusetts (8911)
Michigan (164)
Minnesota (387)
Mississippi (4)
Missouri (59)
Montana (17)
Nebraska (7)
Nevada (79)
New Hampshire (24)
New Jersey (2552)
New Mexico (14)
New York (2714)
North Carolina (1311)
North Dakota (12)
Northern California (5924)
Ohio (287)
Oklahoma (12)
Oregon (31)
Pennsylvania (2124)
Puerto Rico (12)
Rhode Island (40)
South America (285)
South Carolina (20)
South Dakota (1)
Southern California (4507)
Tennessee (80)
Texas (1724)
United States (37402)
Utah (195)
Virginia (219)
Washington D.C. (40)
Washington State (983)
West Virginia (1)
Wisconsin (98)
Wyoming (1)
345,837 Results for "libella gene therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
iCell Gene Therapeutics Announces Upcoming Conference Presentations
October 5, 2026
·
1 min read
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
Encoded Therapeutics’ lead asset ETX101 is a gene therapy being tested for Dravet syndrome. Phase 1/2 data showed substantial reductions in seizures.
September 10, 2026
·
2 min read
·
Tristan Manalac
Gene Therapy
Intellia finds genetic suspect for liver safety signals with ATTR gene therapy
In November 2025, one patient died after receiving Intellia Therapeutics’ investigational gene silencer for transthyretin amyloidosis.
August 7, 2026
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH SK pharmteco
Before GMP: Six manufacturing considerations gene therapy sponsors should address earlier
SK pharmteco’s Tatiana Nanda, chief technical officer of SK pharmteco Viral Vector North America discusses what gene therapy sponsors must account for sooner rather than later when preparing for GMP manufacturing.
November 9, 2026
·
6 min read
·
Jennifer C. Smith-Parker
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At the same time, the Centers for Medicare & Medicaid Services has revealed plans to expand the Cell and Gene Therapy Access Model to increase patient access to these products.
October 28, 2026
·
4 min read
·
Heather McKenzie
Venture capital
Estuary sails into kidney disease space with $103M for gene therapies
Estuary Biotherapeutics is seeking to address the root cause of autosomal dominant polycystic kidney disease with two gene therapy programs based on science from Yale.
October 16, 2026
·
1 min read
·
Annalee Armstrong
Manufacturing
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
The
BioSpace
40 Under 40 honoree helped steer Forge’s sale to Ajinomoto. Now, Samantha Piteri-Molina sees opportunities in AI-driven analytics and Ohio’s gene therapy ecosystem—with a responsibility to patients worldwide.
November 6, 2026
·
4 min read
·
Gabrielle Masson
Opinion
Blood centers can help biopharma scale cell and gene therapies
Blood centers have the donors, resources and community footprint drug sponsors need to solve supply chain issues around cell and gene therapies.
September 15, 2026
·
6 min read
·
Becky Cap
Rett syndrome
Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapy
As both Taysha Gene Therapies and Neurogene warm up for an important year of readouts, the Rett syndrome community is hopeful of seeing a therapy that can truly change the disease’s path.
October 26, 2026
·
6 min read
·
Michael Gibney
FDA
Plug-and-play gene therapy: FDA executes on vision that’s been in the works for years
Former biologics boss Peter Marks had a vision. With the FDA’s latest draft guidance, it’s coming to fruition. Speaking with
BioSpace,
current CBER leader Karim Mikhail said the “adapted pathway” is designed to develop personalized gene therapies more quickly.
November 2, 2026
·
6 min read
·
Heather McKenzie
1 of 34,584
Next